ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
L’Oréal is investing an undisclosed sum in a joint venture led by Genomatica and hopes to use the firm’s biotech products as replacements for traditional ingredients. Genomatica and Unilever launched the JV in June 2022 with a joint investment worth $120 million, describing the project as an effort to develop palm oil alternatives. The chemical company Kao joined the venture later that year. L’Oréal aims to source 95% of its ingredients from renewable or abundant sources by 2030.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter